Nanohale AG (FYB) | WebDisclosure

Basculer en Français

8302	Companies
115108	Keywords
55442	Articles
62528	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 09/17/2024 at 06:55, 2 months 4 days ago

Formycon to Present FYB202 Biosimilar Data at EADV Congress and UEG Week

Clinical Data Biosimilar Formycon FYB202 Ustekinumab
BRIEF

published on 09/17/2024 at 06:55, 2 months 4 days ago

Formycon présentera les données biosimilaires FYB202 au congrès EADV et à la semaine UEG

Formycon FYB202 Ustekinumab Biosimilaire Données Cliniques
PRESS RELEASE

published on 09/17/2024 at 06:50, 2 months 4 days ago

Formycon will present clinical data on its ustekinumab biosimilar candidate FYB202 at the EADV Congress in Amsterdam and the UEG Week in Vienna
Formycon to present clinical data on ustekinumab biosimilar FYB202 at EADV Congress in Amsterdam and UEG Week in Vienna. Biosimilar for psoriasis and IBD in final approval phase

Clinical Data Biosimilar Formycon Ustekinumab Approval Process
BRIEF

published on 08/19/2024 at 14:16, 3 months 2 days ago

First Berlin Equity Research maintient sa note d'achat pour Formycon AG

Acheter Une Note Formycon Biosimilaires Résultats H1/24 Mise À Jour Des Revenus
BRIEF

published on 08/19/2024 at 14:16, 3 months 2 days ago

First Berlin Equity Research Maintains Buy Rating for Formycon AG

BUY Rating Biosimilars Formycon Revenue Update H1/24 Results
PRESS RELEASE

published on 08/19/2024 at 14:11, 3 months 2 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Formycon AG (ISIN: DE000A1EWVY8) with H1/24 results, maintaining BUY rating and EUR 80 target price. Formycon raises FY/24 guidance due to stronger than expected results

First Berlin Equity Research BUY Rating Formycon AG H1/24 Results EUR 80 Target Price
BRIEF

published on 08/13/2024 at 06:55, 3 months 8 days ago

Formycon Reports Robust First Half-Year with Significant Milestones

Financial Results Biosimilars Clinical Milestones Formycon FYB201
BRIEF

published on 08/13/2024 at 06:55, 3 months 8 days ago

Formycon annonce un premier semestre solide avec des étapes importantes

Résultats Financiers Formycon Biosimilaires FYB201 Jalons Cliniques
PRESS RELEASE

published on 08/13/2024 at 06:50, 3 months 8 days ago

Formycon reports a strong first half-year with multiple milestones achieved
Formycon AG reports successful first half-year with key operational, clinical, and regulatory milestones achieved. Group revenue and EBITDA in line with expectations. Invitation to conference call today

Conference Call Revenue Formycon AG Milestones First Half-Year
BRIEF

published on 08/07/2024 at 06:55, 3 months 14 days ago

Formycon Announces Conference Call on 2024 Half-Year Results and Investor Conference Participation

Conference Call Investor Conferences Formycon AG Half-year Results Financial Outlook

Accesswire

Published on 11/21/2024 at 20:15, 35 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 40 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 50 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:25, 1 hour 25 minutes ago

Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Published on 11/21/2024 at 17:35, 3 hours 15 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 1 hour 49 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 2 hours 14 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 2 hours 51 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 2 hours 58 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 2 hours 58 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 13 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 13 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 13 hours 52 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 1 hour ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE